Genetic profile of SNP(s) and ovulation induction

Current Pharmaceutical Biotechnology

Volumn 13, Issue 3, 2012, Pages 417-425

  Loutradis, D ^a   Theofanakis, Ch ^a   Anagnostou, E ^a   Mavrogianni, D ^a   Partsinevelos, G A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Estrogen receptor 1 (ESR1); FSH receptor (FSHR); IVF; Ovarian response; Ovulation induction; Pharmacogenetics; Pharmacogenomics; Single nucleotide polymorphisms (SNPs)

Indexed keywords

ESTROGEN RECEPTOR ALPHA; FOLLITROPIN; FOLLITROPIN RECEPTOR; MUELLERIAN INHIBITING FACTOR;

ARTICLE; CONTROLLED OVARY HYPERSTIMULATION; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GYNECOLOGIC DISEASE; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; INFERTILITY THERAPY; MATERNAL AGE; OVARIAN RESERVE; OVARY FOLLICLE DEVELOPMENT; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY RATE; PREMATURE OVARIAN FAILURE; SINGLE NUCLEOTIDE POLYMORPHISM; SPERMATOGENESIS; TREATMENT RESPONSE;

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENETIC MARKERS; HUMANS; INFERTILITY, FEMALE; OVULATION INDUCTION; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, FSH;

EID: 84857722223     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112799361954     Document Type: Article

References (76)

1. Motulsky, A.G. Drug reactions enzymes, and biochemical genetics. J. Am. Med. Assoc., 1957, 165 (7), 835-837.
2. Loutradis, D.; Vlismas, A.; Drakakis, P.; Antsaklis, A. Pharmacogenetics in ovarian stimulation--current concepts. Ann. N Y. Acad. Sci., 2008, 1127, 10-19.
3. Hopkins, M.M.; Ibarreta, D.; Gaisser, S.; Enzing, C.M.; Ryan, J.; Martin, P.A.; Lewis, G.; Detmar, S.; van der Akker-van Marle, M. E.; Hedgecoe, A.M.; Nightingale, P.; Dreling, M.; Hartig, K.J.; Vullings, W.; Forde, T. Putting pharmacogenetics into practice. Nat. Biotechnol., 2006, 24 (4), 403-10.
4. Nebert, D.W.; Zhang, G.; Vesell, E.S. From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions. Drug Metab. Rev., 2008, 40 (2), 187-224.
5. Meyer, U.A. Pharmacogenetics and adverse drug reactions. Lancet, 2000, 356(9242), 1667-1671.
6. Meyer, U.A.; Zanger, U. M. Molecular mechanisms of genetic polymorphisms of drug metabolism. Annu. Rev. Pharmacol. Toxicol., 1997, 37, 269-296.
7. Lewis, R. An individual approach. Nat. Biotechnol., 2005, 23, 1317-1318.
8. Housman, D.; Ledley, F.D. Why pharmacogenomics? Why now? Nat. Biotechnol., 1998, 16(6), 492-493.
9. Lazarou, J.; Pomeranz, B.H.; Corey, P.N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA, 1998, 279 (15), 1200-1205.
10. Melton, L. Pharmacogenetics and Genotyping: On the trail of SNPs. Nature, 2003, 422, 917-923.
11. Sachidanandam, R.; Weissman, D.; Schmidt, S.C.; Kakol, J.M.; Stein, L.D.; Marth, G.; Sherry, S.; Mullikin, J.C.; Mortimore, B.J.; Willey, D.L.; Hunt, S.E.; Cole, C.G.; Coggill, P.C.; Rice, C.M.; Ning, Z.; Rogers, J.; Bentley, D.R.; Kwok, P.Y.; Mardis, E.R.; Yeh, R.T.; Schultz, B.; Cook, L.; Davenport, R.; Dante, M.; Fulton, L.; Hillier, L.; Waterston, R.H.; McPherson, J.D.; Gilman, B.; Schaffner, S.; Van Etten, W.J.; Reich, D.; Higgins, J.; Daly, M.J.; Blumenstiel, B.; Baldwin, J.; Stange-Thomann, N.; Zody, M.C.; Linton, L.; Lander, E.S.; Altshuler, D. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature, 2001, 409 (6822), 928-33.
12. Marsh, S.; McLeod, H. L. Pharmacogenomics: from bedside to clinical practice. Hum. Mol. Genet., 2006, 15, R89-93.
13. Rosenwanks, Z.; Davis, O. K.; Damario, M. A. The role of maternal age in assisted reproduction. Hum. Reprod., 1995, 10, 165-1673.
14. Marcus, S.F.; Brinsden, P.R. In-vitro fertilization and embryo transfer in women aged 40 years and over. Hum. Reprod. Update, 1996, 2 (6), 495-468.
15. Sills, E.S.; Alper, M.M.; Walsh, A.P. Ovarian reserve screening in infertility: practical applications and theoretical directions for research. Eur. J. Obstet. Gynecol. Reprod. Biol., 2009, 146 (1), 30-36.
16. Chang, M. Y.; Chiang, C. H.; Hsieh, T. T.; Soong, Y.K.; Hsu, K.H. Use of antral follicle count to predict the outcome of assisted reproductive technologies. Fertil. Steril., 1998, 69, 505-510.
17. Chang, M.Y.; Chiang, C.H.; Chiu, T.H.; Hsieh, T.T.; Soong, Y.K. The antral follicle count predicts the outcome of pregnancy in a controlled ovarian hyperstimulation/intrauterine insemination program. J. Assist. Reprod. Genet., 1998, 15(1), 12-17.
18. Chui, D.K.; Pugh, N.D.; Walker, S.M.; Gregory, L.; Shaw, R.W. Follicular vascularity-the predictive value of transvaginal power Doppler ultrasonography in an in-vitro fertilization programme: a preliminary study. Hum. Reprod., 1997, 12(1), 191-196.
19. Shrestha, S.M.; Costello, M.F.; Sjoblom, P.; McNally, G.; Bennett, M.; Steigrad, S.J.; Hughes, G.J. Power Doppler ultrasound assessment of follicular vascularity in the early follicular phase and its relationship with outcome of in vitro fertilization. J. Assist. Reprod. Genet., 2006, 23 (4), 161-169.
20. Syrop, C.H.; Dawson, J.D.; Husman, K. J.; Sparks, A. E.; Van Voorhis, B. J. Ovarian volume may predict assisted reproductive outcomes better than follicle stimulating hormone concentration on day 3. Hum. Reprod., 1999, 14 (7), 1752-1756.
21. Broekmans, F.J.; Kwee, J.; Hendriks, D. J.; Mol, B.W.; Lambalk, C.B. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum. Reprod. Update, 2006, 12 (6), 685-718.
22. Scott, R.T.; Leonardi, M.R.; Hofmann, G.E.; Illions, E.H.; Neal, G.S.; Navot, D. A prospective evaluation of clomiphene citrate challenge test screening of the general fertility population. Obstet. Gynecol., 1993, 82 (4 Pt 1), 539-44.
23. Seifer, D.B.; Lambert-Messerlian, G.; Hogan, J.W.; Gardiner, A.C.; Blazar, A. S.; Berck, C.A. Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil. Steril., 1996, 67(1), 110-114.
24. Smotrich, D.B.; Widra, E.A.; Gindoff, P.R.; Levy, M.J.; Hall, J.L.; Stillman, R.J. Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil. Steril., 1995, 64(6), 1136-1140.
25. Nardo, L.G.; Gelbaya, T.A.; Wilkinson, H.; Roberts, S.A.; Yates, A.; Pemberton, P.; Laing, I. Circulating basal anti-Mullerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil. Steril., 2009, 92 (5), 1586-1593.
26. Laven, J.S.; Mulders, A.G.; Suryandari, D.A.; Gromoll, J.; Nieschlag, E.; Fauser, B.C.; Simoni, M. Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility. Fertil. Steril., 2003, 80 (4), 986-992.
27. Loutradis, D.; Patsoula, E.; Minas, V.; Koussidis, G.A.; Antsaklis, A.; Michalas, S.; Makrigiannakis, A. FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI programs. J. Assist. Reprod. Genet., 2006, 23 (4), 177-184.
28. Georgiou, I.; Konstantelli, M.; Syrrou, M.; Messinis, I.E.; Lolis, D.E. Oestrogen receptor gene polymorphisms and ovarian stimulation for in-vitro fertilization. Hum. Reprod., 1997, 12 (7), 1430-1433.
29. de Castro, F.; Moron, F.J.; Montoro, L.; Galan, J.J.; Hernandez, D. P.; Padilla, E.S.; Ramirez-Lorca, R.; Real, L. M.; Ruiz, A. Human controlled ovarian hyperstimulation outcome is a polygenic trait. Pharmacogenetics, 2004, 14 (5), 285-293.
30. Fauser, B.C.; Van Heusden, A.M. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr. Rev., 1997, 18 (1), 71-106.
31. Simoni, M.; Gromoll, J.; Nieschlag, E. The follicle-stimulating hormone receptor:biochemistry, molecular biology, physiology and pathophysiology. Endocr.Rev., 1997, 18 (6), 739-773.
32. Themmen, A.P. N.; Huhtaniemi, I.T. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr. Rev., 2000, 21 (5), 551-583.
33. Simoni, M.; Nieschlag, E.; Gromoll, J. Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Hum. Reprod. Update, 2002, 8 (5), 413-421.
34. Heckert, L.L.; Daley, I.J.; Griswold, M.D. Structural organisation of the follicle-stimulating hormone receptor gene. Mol. Endocrinol., 1992, 6(1), 70-80.
35. Gromoll, J.; Pekel, E.; Nieschlag, E. The structure and organization of the follicle stimulating hormone receptor (FSHR) gene Genomics, 1996, 35(2), 308-311.
36. Tena-Sempere, M.; Manna, P.R.; Huhtaniemi, I. Molecular cloning of the mouse follicle-stimulating hormone receptor complementary deoxyribonucleic acid: functional expression of alternatively spliced variants and receptor inactivation by a C566T transition in exon 7 of the coding sequence. Biol. Reprod., 1999, 60 (6), 1515-1527.
37. Flores, J.A.; Veldhuis, J.D.; Leong, D.A. Follicle-stimulating hormone evokes an increase in intracellular free calcium ion concentrations in single ovarian (granulosa) cells. Endocrinology, 1990, 127 (6), 3172-3179.
38. Crepieux, P.; Marion, S.; Martinat, N.; Fafeur, V.; Vern, Y.L.; Kerboeuf, D.; Guillou, F.; Reiter, E., The ERK-dependent signalling is stage-specifically modulated by FSH, during primary Sertoli cell maturation. Oncogene, 2001, 20 (34), 4696-4709.
39. Aittomaki, K.; Lucena, J.L.; Pakarinen, P.; Sistonen, P.; Tapanainen, J.; Gromoll, J.; Kaskikari, R.; Sankila, E.M.; Lehvaslaiho, H.; Engel, A.R.; Nieschlag, E.; Huhtaniemi, I.; de la Chapelle, A. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell, 1995, 82 (6), 959-968.
40. Gromoll, J.; Simoni, M.; Nordhoff, V.; Behre, H.M.; De Geyter, C.; Nieschlag, E. Functional and clinical consequenses of mutations in the FSH receptor. Mol, Cell Endocrinol., 1996, 125 (1-2), 177-182.
41. Beau, L.; Touraine, G.; Meduri, G.; Gougeon, A.; Desroches, A.; Matuchansky, C.; Milgrom, E.; Kuttenn, F.; Misrahi, M. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J. Clin. Invest., 1998, 102 (7), 1352-1359.
42. Touraine, P.; Beau, I.; Gougeon, A.; Meduri, G.; Desroches, A.; Pichard, C.; Detoeuf, M.; Paniel, B.; Prieur, M.; Zorn, J. R.; Milgrom, E.; Kuttenn, F.; Misrahi, M. New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype. Mol. Endocrinol., 1999, 13 (11), 1844-1854.
43. Doherty, E.; Pakarinen, P.; Tiitinen, A.; Kiilavuori, A.; Huhtaniemi, I.; Forrest, S.; Aittomaki, K. A Novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. J. Clin. Endocrinol. Metab., 2002, 87 (3), 1151-1155.
44. Allen, L.A.; Achermann, J.C.; Pakarinen, P.; Kotlar, T.J.; Huhtaniemi, I.T.; Jameson, J.L.; Cheetham, T.D.; Ball, S.G. A novel loss of function mutation in exon 10 of the FSH receptor gene causing hypergonadotrophic hypogonadism: clinical and molecular characteristics. Hum. Reprod., 2003, 18 (2), 251-256.
45. Meduri, G.; Touraine, P.; Beau, I.; Lahuna, O.; Desroches, A.; Vacher-Lavenu, M.C.; Kuttenn, F.; Misrahi, M. Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies. J. Clin. Endocrinol. Metab., 2003, 88 (8), 3491-3498.
46. Loutradis, D.; Patsoula, E.; Stefanidis, K.; Drakakis, P.; Antonakis, G.; Bletsa, R.; Antsaklis, A.; Michalas, S. Follicle-stimulating hormone receptor gene mutations are not evident in Greek women with premature ovarian failure and poor responders. Gynecol. Obstet. Invest., 2006, 61(1), 56-60.
47. Huhtaniemi, I.T. The role of mutations affecting gonadotrophin secretion and action in disorders of pubertal development. Best. Pract. Res. Clin. Endocrinol. Metab., 2002, 16 (1), 123-138.
48. Gromoll, J.; Simoni, M. Genetic complexity of FSH receptor function. Trends Endocrinol. Metab., 2005, 16 (8), 368-373.
49. Simoni, M.; Gromoll, J.; Hoppner, W.; Kamischke, A.; Krafft, T.; Stahle, D.; Nieschlag, E. Mutational analysis of the folliclestimulating hormone (FSH) receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. J. Clin. Endocrinol. Metab., 1999, 84 (2), 751-755.
50. Arey, B.J.; Stevis, P. E.; Deecher, D.C.; Shen, E.S.; Frail, D.E.; Negro-Vilar, A.; Lopez, F.J. Induction of promisuous G protein coupling of hte follicle-stimulating hormone (FSH) receptor: A novel mechanism for transducing pleiotropic actions of FSH isoforms. Mol. Endocrinol., 1997, 11(5), 517-526.
51. Davis, D.; Liu, X.; Segaloff, D.L. Identification of the sites of Nlinked glycosylation on the follicle-stimulating hormone (FSH) receptor and assessment of their role in FSH receptor function. Mol. Endocrinol., 1995, 9 (2), 159-170.
52. Perez Mayorga, M.; Gromoll, J.; Behre, H.M.; Gassner, C.; Nieschlag, E.; Simoni, M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J. Clin. Endocrinol. Metab., 2000, 85, 3365-3369.
53. de Castro, F.; Ruiz, R.; Montoro, L.; Perez-Hernandez, D.; Sanchez-Casas Padilla, E.; Real, L.; Ruiz, A. Role of folliclestimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone. Fertil. Steril., 2003, 80 (3), 571-576.
54. Sudo, S.; Kudo, M.; Wada, S.; Sato, O.; Hsueh, A.J.; Fujimoto, S. Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol. Hum. Reprod., 2002, 8 (10), 893-899.
55. Falconer, H.; Andersson, E.; Aanesen, A.; Fried, G. Folliclestimulating hormone receptor polymorphisms in a population of infertile women. Acta Obstet. Gynecol. Scand., 2005, 84 (8), 806-811.
56. Jun, J.K.; Yoon, J.S.; Ku, S.Y.; Choi, Y.M.; Hwang, K.R.; Park, S.Y.; Lee, G. H.; Lee, W.D.; Kim, S.H.; Kim, J.G.; Moon, S.Y. Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVFET. J. Hum. Genet., 2006, 51 (8), 665-670.
57. Klinkert, E.R.; te Velde, E. R.; van Zandvoort, P. M.; Hanssen, R.G.; Nilsson, P.R.; Weima, S.; de Jong, F.H.; Looman, C.W.; Broekmans, F.J. FSH receptor genotype is associated with pregnancy but not with ovarian response in IVF. Reprod. Biomed. Online 2006, 13 (5), 687-695.
58. Conway, G.S.; Conway, E.; Walker, C.; Hoppner, W.; Gromoll, J.; Simoni, M. Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome. Clin. Endocrinol., (Oxf) 1999, 51 (1), 97-99.
59. Sundblad, V.; Chiauzzi, V.A.; Escobar, M.E.; Dain, L.; Charreau, E.H. Screening of FSH receptor gene in Argentine women with premature ovarian failure (POF). Mol. Cell. Endocrinol., 2004, 222 (1-2), 53-59.
60. de Koning, C. H.; Benjamins, T.; Harms, P.; Homburg, R.; van Montfrans, J. M.; Gromoll, J.; Simoni, M.; Lambalk, C.B. The distribution of FSH receptor isoforms is related to basal FSH levels in subfertile women with normal menstrual cycles. Hum. Reprod., 2006, 21 (2), 443-446.
61. Yang, C.Q.; Chan, K.Y.; Ngan, H.Y.; Khoo, U.S.; Chiu, P.M.; Chan, Q.K.; Xue, W.C.; Cheung, A.N. Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility. Carcinogenesis, 2006, 27 (7), 1502-1506.
62. George, F.W.; Wilson, J.D. Sex determination and differentiation. In The Physiology Of Reproduction, Knobil, E.; Neill, I.J., Eds. Raven Press: New York, USA, 1988; pp. 2-27.
63. Filicori, M. The role of luteinizing hormone in folliculogenesis and ovulation induction. Fertil. Steril., 1999, 71 (3), 405-414.
64. Pelletier, G.; El-Alfy, M. Immunocytochemical localization of estrogen receptors alpha and beta in the human reproductive organs. J.Clin. Endocrinol. Metab., 2000, 85 (12), 4835-4840.
65. Altmäe, S.; Haller, K.; Peters, M.; Hovatta, O.; Stavreus-Evers, A.; Karro, H.; Metspalu, A.; Salumets, A. Allelic estrogen receptor 1 (ESR1) gene variants predict the outcome of ovarian stimulation in in vitro fertilization. Mol. Hum. Reprod., 2007, 13 (8), 521-526.
66. Sundarrajan, C.; Liao, W.; Roy, A.C.; Ng, S.C. Association of oestrogen receptor gene polymorphisms with outcome of ovarian stimulation in patients undergoing IVF. Mol. Hum. Reprod., 1999, 5 (9), 797-802.
67. Hsieh, Y. Y.; Wang, Y. K.; Chang, C. C.; Lin, C. S. Estrogen receptor alpha-351 XbaI*G and-397 PvuII*C-related genotypes and alleles are associated with higher susceptibilities of endometriosis and leiomyoma. Mol. Hum. Reprod., 2007, 13 (2), 117-122.
68. Lehrer, S.P.; Schmutzler, R.K.; Rabin, J.M.; Schachter, B.S. An estrogen receptor genetic polymorphism and a history of spontaneous abortions. Correlation in women with estrogen receptor positive breast cancer but not in women with estrogen receptor negative breast cancer or in women without cancer. Breast. Cancer. Res. Treat., 1993, 26(2), 175-180.
69. Sundarrajan, C.; Liao, W.X.; Roy, A.C.; Ng, S.C. Association between estrogen receptor-beta gene polymorphisms and ovulatory dysfunctions in patients with menstrual disorders. J. Clin. Endocrinol. Metab., 2001, 86 (1), 135-139.
70. Corbo, R.M.; Ulizzi, L.; Piombo, L.; Martinez-Labarga, C.; De Stefano, G.F.; Scacchi, R. Estrogen receptor alpha polymorphisms and fertility in populations with different reproductive patterns. Mol. Hum. Reprod., 2007, 13 (8), 537-540.
71. Ayvaz, O.U.; Ekmekçi, A.; Baltaci, V.; Onen, H.I.; Unsal, E. Evaluation of in vitro fertilization parameters and estrogen receptor alpha gene polymorphisms for women with unexplained infertility. J. Assist. Reprod. Genet., 2009, 26 (9-10), 503-510.
72. Aittomaki, K.; Herva, R.; Stenman, U.H.; Juntunen, K.; Ylostalo, P.; Hovatta, O.; de la Chapelle, A. Clinical features of primary ovarian failure caused by a point mutation in the folliclestimulating hormone receptor gene. J. Clin. Endocrinol. Metab., 1996, 81 (10), 3722-3726.
73. Kukuvitis, A.; Georgiou, I.; Bouba, I.; Tsirka, A.; Giannouli, C. H.; Yapijakis, C.; Tarlatzis, B.; Bontis, J.; Lolis, D.; Sofikitis, N.; Papadimas, J. Association of oestrogen receptor alpha polymorphisms and androgen receptor CAG trinucleotide repeats with male infertility: a study in 109 Greek infertile men. Int. J. Androl., 2002, 25 (3), 149-152.
74. Syrrou, M.; Georgiou, I.; Patsalis, P.C.; Bouba, I.; Adonakis, G.; Pagoulatos, G.N. Fragile X premutations and (TA)n estrogen receptor polymorphism in women with ovarian dysfunction. Am. J. Med. Genet., 1999, 84 (3), 306-308.
75. Schuit, S.C.; de Jong, F.H.; Stolk, L.; Koek, W.N.; van Meurs, J.B.; Schoofs, M.W.; Zillikens, M.C.; Hofman, A.; van Leeuwen, J. P.; Pols, H.A.; Uitterlinden, A.G. Estrogen receptor alpha gene polymorphisms are associated with estradiol levels in postmenopausal women. Eur. J. Endocrinol., 2005, 153 (2), 327-334.
76. Anagnostou, E.; Mavrogianni, D.; Theofanakis, C.; Drakakis, P.; Bletsa, R.; Demirol, A.; Gurgan, T.; Antsaklis, A.; Loutradis, D. ESR1, ESR2 and FSH Receptor gene polymorphisms in combination: a useful genetic tool for the prediction of poor responders. Curr. Pharm. Biotechnol., 2011, 13(3), 417-425.